Antiobesity Medication Use in 2.2 Million Adults Across Eight Large Health Care Organizations: 2009‐2015-Reference-Cited by-同舟云学术

Antiobesity Medication Use in 2.2 Million Adults Across Eight Large Health Care Organizations: 2009‐2015

Published:2019-10-11 Issue:12 Volume:27 Page:1975-1981
ISSN:1930-7381
Container-title:Obesity
language:en
Short-container-title:Obesity

Author:

Saxon David R.¹²^ORCID,Iwamoto Sean J.¹²^ORCID,Mettenbrink Christie J.³,McCormick Emily³,Arterburn David⁴,Daley Matthew F.⁵,Oshiro Caryn E.⁶,Koebnick Corinna⁷,Horberg Michael⁸,Young Deborah R.⁸^ORCID,Bessesen Daniel H.¹³

Affiliation:

1. Division of Endocrinology, Metabolism and Diabetes University of Colorado, Anschutz Medical Campus Aurora Colorado USA

2. Division of Endocrinology Rocky Mountain Regional Veterans Affairs Medical Center Aurora Colorado USA

3. Denver Health Medical Center Denver Colorado USA

4. Kaiser Permanente Washington Health Research Institute Seattle Washington USA

5. Kaiser Permanente Colorado Institute for Health Research Denver Colorado USA

6. Kaiser Permanente Center for Health Research Hawaii Honolulu Hawaii USA

7. Department of Research and Evaluation Kaiser Permanente Pasadena California USA

8. Kaiser Permanente Mid‐Atlantic Permanente Research Institute Rockville Maryland USA

Funder

National Institute of Diabetes and Digestive and Kidney Diseases

National Institutes of Health

Patient-Centered Outcomes Research Institute

Publisher

Wiley

Subject

Nutrition and Dietetics,Endocrinology,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/oby.22581

Reference26 articles.

1. Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007-2008 to 2015-2016

2. evaluation, and treatment of overweight and obesity in adults‐the evidence report. National Institutes of Health;Clinical guidelines on the identification;Obes Res,1998

3. Guidelines (2013) for managing overweight and obesity in adults;Jensen MD;Obesity (Silver Spring),2014

4. Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline

5. 8. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes—2019

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “What would be left of me?” Patient perspectives on the risks of obesity treatment: An innovative health initiative stratification of obesity phenotypes to optimise future obesity therapy (IMI2 SOPHIA) qualitative study;Obesity Pillars;2024-12

2. Therapeutic inertia in obesity management among people living with obesity from the perspective of general/family practitioners in Canada: A mixed‐methods study;Clinical Obesity;2024-09-03

3. Patients experience with preoperative use of anti-obesity medications and associations with bariatric surgery expectations.;Surgery for Obesity and Related Diseases;2024-09

4. Medications for Obesity;JAMA;2024-08-20

5. Eligibility for obesity management in Peru: Analysis of National Health Surveys from 2014 to 2022;Wellcome Open Research;2024-08-19